Literature DB >> 28503886

Life-threatening drug interactions: what the physician needs to know.

Richard O Day1,2,3, Leone Snowden4, Andrew J McLachlan5.   

Abstract

Adverse drug-drug interactions are a significant cause of adverse events and outcomes. Their incidence is rising, with more patients taking more drugs, and newer, more precise but often more hazardous drugs becoming available. Despite considerable information, including computerised alerts about potential adverse drug-drug interactions, prescribers increasingly override alerts, possibly symptomatic of the immense problem of evaluating the risk of an interaction in a particular patient. Many reports emanate from small studies often of normal and young volunteers, entirely different from the real world where, more often, older patients with multiple health conditions are receiving many more than the two drugs identified in the drug interaction report. Focusing on those drug-drug interactions that are clinically relevant is necessary, and increasingly, tools and reliable sources of this information are easily accessible.
© 2017 Royal Australasian College of Physicians.

Entities:  

Keywords:  adverse drug events; adverse drug reactions; cytochrome P 450 metabolism; drug-drug interactions; pharmacodynamic drug interactions; pharmacokinetic drug interactions

Mesh:

Substances:

Year:  2017        PMID: 28503886     DOI: 10.1111/imj.13404

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  9 in total

1.  Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Authors:  S M M Meslin; W Y Zheng; R O Day; E M Y Tay; M T Baysari
Journal:  Appl Clin Inform       Date:  2018-11-28       Impact factor: 2.342

2.  Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant.

Authors:  Min-Hui Tan; Seow-Yeing Yee; Rosnawati Yahya
Journal:  Clin Med (Lond)       Date:  2022-03       Impact factor: 5.410

3.  Advancement in predicting interactions between drugs used to treat psoriasis and its comorbidities by integrating molecular and clinical resources.

Authors:  Matthew T Patrick; Redina Bardhi; Kalpana Raja; Kevin He; Lam C Tsoi
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

4.  Menstrual Dysfunction and Treatment Among Adolescents With Congenital Heart Disease.

Authors:  Maayan Leroy-Melamed; Amy Katz; Marcia L Shew
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-08-20       Impact factor: 2.046

5.  Iatrogenic Cushing's syndrome with inhaled fluticasone.

Authors:  Thomas Ledger; Winnie Tong; Janet Rimmer
Journal:  Aust Prescr       Date:  2019-08-01

Review 6.  Drug interaction resources: mind the gaps.

Authors:  Louise Grannell
Journal:  Aust Prescr       Date:  2020-02-03

7.  Predictors of drug-drug interactions of medications prescribed to patients admitted due to suicidal behavior.

Authors:  Amanda Sarah Vanzela; Aline Conceição Silva; Tatiana Longo Borges; Ellen Carolina Dias Castilho; Adriana Inocenti Miasso; Ana Carolina Guidorizzi Zanetti; Jonas Bodini Alonso; Kelly Graziani Giacchero Vedana
Journal:  Heliyon       Date:  2022-01-31

Review 8.  The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare.

Authors:  Ioannis Stouras; Theodore G Papaioannou; Konstantinos Tsioufis; Aristides G Eliopoulos; Despina Sanoudou
Journal:  J Pers Med       Date:  2022-03-22

9.  Hyperkinetic reaction to dihydrocodeine.

Authors:  James David van Oppen; Neeta Patel; Aamir Tarique
Journal:  BMJ Case Rep       Date:  2020-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.